Singapore markets open in 17 minutes

Straits Times Index
3,110.73
+36.47(+1.19%)
S&P 500
4,604.37
+18.78(+0.41%)
Dow
36,247.87
+130.47(+0.36%)
Nasdaq
14,403.97
+63.97(+0.45%)
Bitcoin USD
43,742.39
-25.90(-0.06%)
CMC Crypto 200
905.23
+8.52(+0.95%)

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

9.62

+0.03

(+0.31%)

At close: 04:00PM EST

9.61

-0.01

(-0.10%)

After hours:

07:18PM EST

Trade prices are not sourced from all markets

All

Business Wire
Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
SAN FRANCISCO, December 06, 2023--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Vir’s Chief Executive Officer, will present at the J.P. Morgan 2024 42nd Annual Healthcare Conference on Wednesday, January 10, at 3:45 p.m. PT / 6:45 p.m. ET.
Business Wire
Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023
SAN FRANCISCO, November 13, 2023--Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023
Business Wire
Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023
SAN FRANCISCO, November 10, 2023--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that it will be presenting new data from its Phase 2 trials evaluating the potential clinical impact that VIR-3434 and VIR-2218 could have for chronic hepatitis B (CHB) and chronic hepatitis delta (CHD) patients at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting®, taking place in Boston, MA, from November 10-14, 2023. These include one late-breaking poster presentation and o